Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Melissa Barger"'
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Vancomycin resistant enterococci (VRE) infections are of increasing concern in many hospitalized patients. Patients with cirrhosis are at added risk of infection with VRE, with associated increased risk for complications from infe
Externí odkaz:
https://doaj.org/article/ae681c14eec448e0830aa5cf0eb17b1b
Autor:
Andrew J Webb, Carly Wadle, Taylor Morrisette, Iman Ansari, Keira A. Cohen, Jeannette Bouchard, Tristan W Gore, Michael P. Veve, Sara Alosaimy, Abdalhamid M Lagnf, Michael J. Rybak, Melissa Barger, Carlos Mejia-Chew, Catessa Howard, Julie V. Philley
Publikováno v:
Open Forum Infectious Diseases
Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for Mycobacterium abscessus. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2–11.0)
Autor:
Kai-Yin See, Vivek Patel, Kyle Hurth, Emily Blodget, Gabriel Zada, Alexander Lerner, Kimberly K. Gokoffski, Kirt Gill, Linda J Szymanski, James C. Hu, Naveed Wagle, Chia-Shang J. Liu, Mark S. Shiroishi, Melissa Barger, Anandh G. Rajamohan
Publikováno v:
Radiology of Infectious Diseases, Vol 4, Iss 3, Pp 121-127 (2017)
A 31 year-old man with HIV and pulmonary tuberculosis (TB) status-post RIPE regimen presented with cough and throbbing headaches. Laboratory results were remarkable for a CD4 count of 2 kcells/L and a viral load of 2.7 million copies/mL. MRI of the b
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
Background Vancomycin resistant enterococci (VRE) infections are of increasing concern in many hospitalized patients. Patients with cirrhosis are at added risk of infection with VRE, with associated increased risk for complications from infections. T
Autor:
Abdalhamid M Lagnf, Jeremy J Frens, Sara Alosaimy, Melissa Barger, Jeannette Bouchard, Taylor Morrisette, Carly Sigler, Michael J. Rybak, P B Bookstaver, Catessa Howard, Andrew J Webb, Julie V. Philley, Ryan W. Stevens
Publikováno v:
Open Forum Infectious Diseases
Background Omadacycline (OMC) is an aminomethylcycline antibiotic in the tetracycline class that has been Food and Drug Administration-approved for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. OMC has
Autor:
Jeffrey Fried, Melissa Barger
Publikováno v:
Open Forum Infectious Diseases. 3